Within the cohort of patients with acute PE, 1,273 (n = 297 aged 0-9; n = 978 aged 10-19) had high-risk features, whereas the remainder did not have these features.

An analysis of more than 1.6 million emergency department (ED) visits for acute pulmonary embolism (PE) has found that nearly two-thirds of ED visits still resulted in hospitalization for low-risk ...

The FlowTriever percutaneous mechanical thrombectomy system (Inari Medical) is safe and provides immediate benefits to patients with acute pulmonary embolism (PE), interim results of the real-world ...

Overall, 30.7% of patients with acute PE were discharged from the ED over 9 years. Discharge rates, while remaining constant over time, were 38.2% between 2012 and 2014 and 33.4% between 2018 and ...

LAS VEGAS — In the EXTRACT-PE trial, an aspiration mechanical thrombectomy device was safe and effective among patients with acute pulmonary embolism, researchers reported at VIVA 19.The device ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results ...

The Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV) treated 122 patients with the system, which the FDA approved for the treatment of PE. At 48 hours after the ...